Skip to content

Clinical trials

Encephalitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Encephalitis Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20034
20052
20061
20072
20081
20092
20103
20111
20121
20133
20146
20153
20165
20176
20185
20198
202011
20217
20227
20238
20245
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting20
Unknown status20
Withdrawn6
Not yet recruiting5
Terminated2
Active, not recruiting2
No longer available1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)8
Arialys Therapeutics2
Assistance Publique - Hôpitaux de Paris2
Assiut University2
Chelsea and Westminster NHS Foundation Trust2
Fundacion Clinic per a la Recerca Biomédica2
Hospices Civils de Lyon2
Inflammatix2
Johns Hopkins University2
MacroGenics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Encephalitis116
Meningitis29
Stroke11
Autoimmune Diseases of the Nervous System10
Brain Injuries, Traumatic10
Virus Diseases10
HIV Infections8
Acquired Immunodeficiency Syndrome7
Brain Diseases7
Central Nervous System Infections7

Trials

Showing 76 to 100 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.